Apoquel (oclacitinib) chewable tablet for Dogs, 3.6 mg

• #1 Prescribed Oral Medicine for Allergic Itch(1)
• Stops allergic itch at the source(5)
• Fast-Acting Allergy Itch Relief
• Can be used with many other medications(3)
• Apoquel Chewable is a tasty pork-liver flavor

IMPORTANT SAFETY INFORMATION: Do not use Apoquel or Apoquel Chewable in dogs less than 12 months of age or those with serious infections. Apoquel and Apoquel Chewable may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse. Consider the risks and benefits of treatment in dogs with a history of recurrence of these conditions. New neoplastic conditions (benign and malignant) were observed in clinical studies and post approval. Apoquel and Apoquel Chewable have not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporines. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. Apoquel and Apoquel Chewable have been used safely with many common medications including parasiticides, antibiotics and vaccines. See full Prescribing Information for Apoquel Tablet at ApoquelPI.com and full Prescribing Information for Apoquel Chewable at ApoquelChewablePI.com.
 

INDICATIONS: Control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.
 

*Vets, n=250, Pet Owners, n=491
 

References:
 

1. Data on file, PetTrak Total Unique Patient Count, December 2022, Zoetis Inc. (TI-09437)
 

2. Data on file: Study Report A161C-US-21-C02, Zoetis Inc., 2022 (TI-09898)
 

3. Cosgrove SB, Cleaver DM, King VL, et al. Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life. Vet Dermatol. 2015;26(3):171-179, e35. doi:10.1111/vde.12194  (AR-01949)
 

5. Gonzales AJ, Bowman JW, Fici GJ, et al. Oclacitinib (APOQUEL)is a novel Janus kinase inhibitor with activity against cytokines involved in allergy. J Vet Pharmacol Therapy. 2014;37(4)317-24. doi:10.1111/jvp.12101 (AR-00542)
 

6. Data on file, Apoquel Cytopoint Vet Tracker Wave 11 (December 20 2018) (TI-04447)
 

7. Data on file, APOQUEL/CYTOPOINT Pet Owner Tracker Wave 11, 2022, Zoetis Inc. (TI-08418)